Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$120M Sell
436,592
-322,051
-42% -$91M 0.02% 453
2026
Q1
$202M Buy
758,643
+238,727
+46% +$66.1M 0.05% 293
2025
Q4
$143M Sell
519,916
-113,414
-18% -$31.8M 0.03% 368
2025
Q3
$183M Sell
633,330
-106,368
-14% -$31.5M 0.04% 321
2025
Q2
$245M Buy
739,698
+143,772
+24% +$46.3M 0.06% 230
2025
Q1
$196M Buy
595,926
+102,721
+21% +$30.9M 0.06% 254
2024
Q4
$136M Sell
493,205
-160,913
-25% -$51.3M 0.04% 321
2024
Q3
$227M Sell
654,118
-173,262
-21% -$59.6M 0.06% 232
2024
Q2
$274M Sell
827,380
-195,458
-19% -$67.4M 0.08% 177
2024
Q1
$371M Sell
1,022,838
-48,904
-5% -$16.1M 0.13% 131
2023
Q4
$321M Sell
1,071,742
-19,631
-2% -$5.74M 0.12% 143
2023
Q3
$312M Buy
1,091,373
+142,525
+15% +$40.6M 0.19% 103
2023
Q2
$266M Buy
948,848
+162,521
+21% +$42.3M 0.17% 120
2023
Q1
$201M Sell
786,327
-242,359
-24% -$70.6M 0.09% 140
2022
Q4
$341M Buy
1,028,686
+119,598
+13% +$37.8M 0.15% 97
2022
Q3
$252M Sell
909,088
-115,085
-11% -$32.4M 0.28% 71
2022
Q2
$270M Sell
1,024,173
-64,910
-6% -$16.7M 0.17% 86
2022
Q1
$261M Sell
1,089,083
-361,853
-25% -$84.7M 0.2% 110
2021
Q4
$333M Buy
1,450,936
+491,004
+51% +$104M 0.12% 135
2021
Q3
$192M Buy
959,932
+136,953
+17% +$29.8M 0.09% 185
2021
Q2
$195M Buy
822,979
+124,162
+18% +$31M 0.09% 180
2021
Q1
$169M Sell
698,817
-39,524
-5% -$8.81M 0.09% 178
2020
Q4
$154M Sell
738,341
-41,147
-5% -$8.07M 0.08% 183
2020
Q3
$132M Buy
779,488
+182,039
+30% +$32M 0.08% 179
2020
Q2
$112M Sell
597,449
-146,942
-20% -$27.9M 0.09% 165
2020
Q1
$132M Sell
744,391
-448,503
-38% -$87M 0.1% 130
2019
Q4
$244M Buy
1,192,894
+317,113
+36% +$58.1M 0.14% 117
2019
Q3
$133M Sell
875,781
-48,235
-5% -$7.85M 0.08% 193
2019
Q2
$146M Buy
924,016
+281,947
+44% +$44.2M 0.09% 185
2019
Q1
$103M Sell
642,069
-45,020
-7% -$8.22M 0.07% 222
2018
Q4
$130M Buy
687,089
+188,831
+38% +$39.4M 0.1% 142
2018
Q3
$104M Buy
498,258
+24,106
+5% +$4.47M 0.07% 202
2018
Q2
$80.6M Sell
474,152
-184,900
-28% -$32M 0.07% 233
2018
Q1
$111M Buy
659,052
+92,197
+16% +$17.9M 0.08% 197
2017
Q4
$115M Buy
566,855
+312,536
+123% +$62.2M 0.09% 170
2017
Q3
$47.5M Buy
254,319
+20,319
+9% +$3.62M 0.05% 312
2017
Q2
$39.2M Buy
234,000
+1,060
+0.5% +$170K 0.04% 357
2017
Q1
$34.1M Sell
232,940
-85,035
-27% -$12.5M 0.04% 360
2016
Q4
$42.4M Buy
317,975
+190,766
+150% +$25M 0.05% 313
2016
Q3
$16.6M Sell
127,209
-65,653
-34% -$8.57M 0.02% 627
2016
Q2
$24.7M Buy
192,862
+22,813
+13% +$3.01M 0.03% 441
2016
Q1
$23.3M Sell
170,049
-73,486
-30% -$10.1M 0.04% 425
2015
Q4
$35.6M Sell
243,535
-138,064
-36% -$19M 0.04% 372
2015
Q3
$51.5M Buy
381,599
+93,969
+33% +$13.6M 0.06% 264
2015
Q2
$46.6M Sell
287,630
-324,918
-53% -$44.9M 0.05% 308
2015
Q1
$79M Buy
612,548
+252,226
+70% +$29.3M 0.09% 203
2014
Q4
$36.8M Sell
360,322
-65,873
-15% -$6.49M 0.04% 467
2014
Q3
$38.4M Sell
426,195
-128,918
-23% -$12M 0.04% 418
2014
Q2
$50.5M Buy
555,113
+21,480
+4% +$1.84M 0.05% 311
2014
Q1
$44.3M Buy
533,633
+16,661
+3% +$1.37M 0.05% 334
2013
Q4
$45M Buy
516,972
+3,483
+0.7% +$285K 0.05% 378
2013
Q3
$39M Sell
513,489
-57,714
-10% -$4.51M 0.05% 371
2013
Q2
$41.4M Buy
+571,203
New +$38.5M 0.05% 313

Other funds holding CI

Barclays's CI Position: Q2 2026 in Review

Barclays reduced its Cigna (CI) stake by 42% in Q2 2026, selling an estimated $91M and leaving 436,592 shares worth $120M. The position accounts for 0.02% of the portfolio, ranked #453.

Barclays first reported a position in CI in Q2 2013 and has held it in 53 quarters since. The position peaked at $371M in Q1 2024. 1,699 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Barclays held 436,592 shares of Cigna worth $120M as of Q2 2026.
  • Barclays sold 322,051 Cigna shares in Q2 2026, an estimated $91M.
  • Cigna made up 0.02% of Barclays's portfolio in Q2 2026, its #453 holding.
  • Barclays first reported a position in Cigna in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Cigna position peaked at $371M in Q1 2024.
  • 1,699 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.